CJC-1295 Without DAC

CJC-1295 without DAC is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Unlike the DAC-modified form, it is designed for a shorter duration of activity and has been studied in laboratory and preclinical research for its interaction with growth hormone signaling pathways and related endocrine processes.

Research Overview

Published preclinical research involving CJC-1295 without DAC has explored areas including:

• Growth hormone-releasing hormone receptor activity
• Growth hormone signaling pathways
• Pulsatile endocrine signaling
• IGF-1-related research models
• Metabolic signaling pathways
• Body-composition and energy-balance research models
• Recovery and tissue-response pathways

CJC-1295 without DAC remains an investigational research compound. Findings from laboratory, cellular, or animal studies should not be interpreted as demonstrating safety, effectiveness, or therapeutic benefit in humans.